Skip to main content
. 2021 Oct 18;12:723577. doi: 10.3389/fmicb.2021.723577

TABLE 3.

Revised accuracy of different methods on GEBA, FDA-ARGROS, and NCTC 3000 datasets.

Expecteda 16Sb KmerFinder (Com)c KmerFinder (type)d fIDBACe fIDBAC-ANI (95%)f
GEBA 973 617 (63.41%) 272 (27.95%) 908 (93.32%) 963 (98.97%) 963 (98.97%)
FDA-ARGROS 505 364 (72.08%) 478 (94.65%) 429 (84.95%) 501 (99.21%) 488 (96.63%)
NCTC-3000 967 644 (66.60%) 880 (91.00%) 671 (69.38%) 962 (99.48%) 951 (98.34%)
Total 2,445 1,625 (66.46%) 1,630 (66.67%) 2,008 (82.12%) 2,427 (99.26%) 2,402 (98.24%)

aExpected, the number of query genomes.

b16S, number of 16S top 1 result that matches the original label.

cKmerFinder (Com), number of KmerFinder top 1 result with its complete genome database that matches the original label.

dKmerFinder (type), number of KmerFinder top 1 result with its type-strain genome database that matches the original label.

efIDBAC, number of fIDBAC top 1 result with its curated genome database that matches the original label.

ffIDBAC, number of fIDBAC top 1 result with its curated genome database that matches the 95% ANI threshold and the original label.